Open Orphan #ORPH – Ethics approval – COVID-19 Human Challenge Study February 17, 2021 – Posted in: Blog, Open Orphan (ORPH)

Open Orphan (AIM: ORPH), a rapidly growing specialist pharmaceutical services clinical research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces the world’s first COVID-19 characterisation study has received approval from a specially convened Research Ethics Committee (“REC”). This news follows the announcement on 20 October 2020 of Open Orphan subsidiary hVIVO’s contract with the UK Government to develop a COVID-19 human challenge study model. The…

Pharma Tech Article – Open Orphan #ORPH – Accelerated Vaccine Development with Human Challenge Studies December 7, 2020 – Posted in: Open Orphan (ORPH)

Pharma Tech Article – Open Orphan #ORPH – Accelerated Vaccine Development with Human Challenge Studies Pharmaceutical companies worldwide are joining global efforts to combat, diagnose, treat and prevent infections from COVID-19. As we have seen, the search for vaccines and possible treatment to curb the transmission and reduce the mortality and morbidity produced by the virus is in overdrive. Link here to read the full article…

Open Orphan #ORPH – Ethics approval – COVID-19 Human Challenge Study February 17, 2021 – Posted in: Blog, Open Orphan (ORPH)

Pharma Tech Article – Open Orphan #ORPH – Accelerated Vaccine Development with Human Challenge Studies December 7, 2020 – Posted in: Open Orphan (ORPH)

Address

Contact

Social

LEGAL